-
A revised lawsuit filed by Missouri, Idaho, and Kansas seeks to reverse FDA regulations on mifepristone, the abortion pill. The states aim to impose stricter access rules, including limiting its use to those over 18 and requiring in-person consultations, amid ongoing debates over abortion rights in the U.S.
-
Following Donald Trump's election victory, reproductive healthcare advocates express alarm over potential restrictions on abortion rights. While several states passed measures to protect abortion access, Trump's administration may pursue aggressive actions against reproductive healthcare, including possible federal bans and restrictions on abortion medications.
-
Following Donald Trump's election victory, requests for abortion pills and emergency contraception have surged dramatically. Providers report unprecedented demand, with many women stockpiling medications amid fears of potential restrictions under the incoming administration. This trend mirrors past spikes seen after significant political events affecting reproductive rights.